The systemic effect of bromhexine ('Bisolvon') in normal subjects.
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D001806:Blood Urea Nitrogen; D001964:Bromhexine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D002118:Calcium / Q000097:blood / Q000652:urine; D002784:Cholesterol / Q000097:blood; D003238:Connective Tissue / Q000187:drug effects / Q000378:metabolism; D003404:Creatinine / Q000097:blood / Q000652:urine; D004573:Electrolytes / Q000097:blood; D006025:Glycosaminoglycans / Q000652:urine; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D010710:Phosphates / Q000097:blood; D012709:Serum Albumin / Q000032:analysis
D001798:Blood Proteins; D004573:Electrolytes; D006025:Glycosaminoglycans; D010710:Phosphates; D012709:Serum Albumin; D002784:Cholesterol; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001964:Bromhexine; D001663:Bilirubin; D006909:Hydroxyproline; D002118:Calcium